Cigarette
smoke contains relatively large quantities of volatile organic toxicants or
carcinogens such as
benzene,
acrolein, and
crotonaldehyde. Among their detoxification products are mercapturic
acids formed from
glutathione conjugation, catalyzed in part by
glutathione S-
transferases (GST). A randomized phase II clinical trial with a crossover design was conducted to evaluate the effect of 2-phenethyl
isothiocyanate (
PEITC), a natural product formed from
gluconasturtiin in certain cruciferous vegetables, on the detoxification of
benzene,
acrolein, and
crotonaldehyde in 82 cigarette smokers. Urinary mercapturic
acids of
benzene,
acrolein, and
crotonaldehyde at baseline and during treatment were quantified. Overall, oral
PEITC supplementation increased the
mercapturic acid formed from
benzene by 24.6% (P = 0.002) and
acrolein by 15.1% (P = 0.005), but had no effect on
crotonaldehyde. A remarkably stronger effect was observed among subjects with the null genotype of both GSTM1 and GSTT1: in these individuals,
PEITC increased the detoxification metabolite of
benzene by 95.4% (P < 0.001), of
acrolein by 32.7% (P = 0.034), and of
crotonaldehyde by 29.8% (P = 0.006). In contrast,
PEITC had no effect on these mercapturic
acids in smokers possessing both genes.
PEITC had no effect on the urinary oxidative stress
biomarker 8-iso-prostaglandin F2α or the
inflammation biomarker prostaglandin E2 metabolite. This trial demonstrates an important role of
PEITC in detoxification of
environmental carcinogens and toxicants which also occur in cigarette
smoke. The selective effect of
PEITC on detoxification in subjects lacking both GSTM1 and GSTT1 genes supports the epidemiologic findings of stronger protection by dietary
isothiocyanates against the development of
lung cancer in such individuals.
Cancer Prev Res; 9(7); 598-606. ©2016 AACR.